Drs. Chang and Chagan review posaconazole (Noxafil) for fungal infections.
You are here
P&T® Journal contents for July 2008
An in-depth interview with the director of the FDA’s Center for Drug Evaluation and Research reveals a conscientious leader who is receiving high marks for her candor about the agency’s challenges.
Presentations cover therapies for breast cancer, renal cell carcinoma, chronic myelogenous leukemia, non–small-cell lung cancer, bone resorption, and melanoma.
Continuing Education Credit
Migraine is the most common headache complaint in clinical practice. Part 1 of a two-part series presents a summary of treatments used to reduce the severity and duration of migraine and its associated symptoms and also discusses the comorbidities, clinical presentation, and risk factors associated with this affliction.
In 2001, The Joint Commission released new pain guidelines and attempted to address the problem of undertreated pain; however, the resulting focus on the pain score number has inadvertently led to some serious adverse drug events. In addition, the recent dramatic increase in opioid use has resulted in greater abuse of these prescribed drugs, often by teenagers.